Association of co-occurring gene alterations and clinical activity of rucaparib in patients with BRCA1 or BRCA2 mutated (BRCA plus ) metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Abida, W.; Patnaik, A.; Campbell, D.; Shapiro, J. D.; Bryce, A. H.; McDermott, R. S.; Sautois, B.; Vogelzang, N. J.; Bambury, R. M.; Voog, E.; Zhang, J.; Piulats, J. M.; Ryan, C. J.; Merseburger, A. S.; Fizazi, K.; Despain, D.; Loehr, A.; Dowson, M.; Golsorkhi, T.; Chowdhury, S.
Abstract Title: Association of co-occurring gene alterations and clinical activity of rucaparib in patients with BRCA1 or BRCA2 mutated (BRCA plus ) metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 2021 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 6 Suppl.
Meeting Dates: 2021 Feb 11-13
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-02-20
Language: English
ACCESSION: WOS:000636801500131
DOI: 10.1200/JCO.2021.39.6_suppl.80
PROVIDER: wos
Notes: Meeting Abstract: 80 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wassim Abida
    154 Abida